1974•JAMARequires access

Aspirin Can Be Dangerous

HUGH HUDSON HUSSEY

Open publisher page 2 citations

Abstract

Aspirin (acetylsalicylic acid) prolongs the bleeding time in normal persons by diminishing platelet adhesiveness, thereby interfering with the platelet aggregation so necessary for hemostasis. In patients with hemophilia, prolongation of bleeding time is even more pronounced when aspirin is administered, and it may potentiate or contribute to initiation of hemorrhage. Since sodium salicylate does not alter the bleeding time, the effect of aspirin has been ascribed to the acetyl radical. Studies by Sutor et al 1 demonstrated that acetaminophen (Tylenol) also does not interfere with hemostasis. With these thoughts in mind, Binder and his co-workers, in the March issue of American Journal of Diseases of Children (127:371-373, 1974), have published their study of the effect on bleeding time of other common analgesic and anti-inflammatory agents that might be used for relief of pain in a patient with hemophilia. The authors note at the outset that pain in hemophilia is one

About this research paper

What this paper is about

Aspirin (acetylsalicylic acid) prolongs the bleeding time in normal persons by diminishing platelet adhesiveness, thereby interfering with the platelet aggregation so necessary for hemostasis. In patients with hemophilia, prolongation of bleeding time is even more pronounced when aspirin is administered, and it may potentiate or contribute to initiation of hemorrhage. Since sodium salicylate does not alter the bleeding time, the effect of aspirin has been ascribed to the acetyl radical. Studies by Sutor et al 1 demonstrated that acetaminophen (Tylenol) also does not interfere with hemostasis. With these thoughts in mind, Binder and his co-workers, in the March issue of American Journal of Diseases of Children (127:371-373, 1974), have published their study of the effect on bleeding time of other common analgesic and anti-inflammatory agents that might be used for relief of pain in a patient with hemophilia. The authors note at the outset that pain in hemophilia is one

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aspirin (acetylsalicylic acid) prolongs the bleeding time in normal persons by diminishing platelet adhesiveness, thereby interfering with the platelet aggregation so necessary for hemostasis. In patients with hemophilia, prolongation of bleeding time is even more pronounced when aspirin is administered, and it may potentiate or contribute to initiation of hemorrhage. Since sodium salicylate does not alter the bleeding time, the effect of aspirin has been ascribed to the acetyl radical. Studies by Sutor et al 1 demonstrated that acetaminophen (Tylenol) also does not interfere with hemostasis. With these thoughts in mind, Binder and his co-workers, in the March issue of American Journal of Diseases of Children (127:371-373, 1974), have published their study of the effect on bleeding time of other common analgesic and anti-inflammatory agents that might be used for relief of pain in a patient with hemophilia. The authors note at the outset that pain in hemophilia is one

Key concepts: Medicine, Aspirin, Intensive care medicine, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Aspirin Can Be Dangerous — Research Paper | ScholarLens